Japan Covid-19 Diagnostics Market Size & Outlook
Japan covid-19 diagnostics market, 2020-2030 (US$M)
Related Markets
Japan covid-19 diagnostics market highlights
- The Japan covid-19 diagnostics market generated a revenue of USD 729.7 million in 2023 and is expected to reach USD 59.2 million by 2030.
- The Japan market is expected to grow at a CAGR of -30.2% from 2024 to 2030.
- In terms of segment, reagents & kits was the largest revenue generating product in 2023.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Covid-19 diagnostics market data book summary
| Market revenue in 2023 | USD 729.7 million |
| Market revenue in 2030 | USD 59.2 million |
| Growth rate | -30.2% (CAGR from 2023 to 2030) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data | 2020 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Kits, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Hologic Inc, Roche, PerkinElmer, Veredus Laboratories, QuidelOrtho Corp, Quest Diagnostics Inc, Luminex, Labcorp Holdings Inc, Abbott Laboratories, 1Drop Diagnostics, ADT Inc, Mylab Discovery Solutions, Neuberg Diagnostics, Aldatu Biosciences, altona Diagnostics GmbH |
Other key industry trends
- In terms of revenue, Japan accounted for 2.2% of the global covid-19 diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, India covid-19 diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 52.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
COVID-19 Diagnostics Market Scope
COVID-19 Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan covid-19 diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 67.41% in 2023. Horizon Databook has segmented the Japan covid-19 diagnostics market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2020 to 2030.
With the development of rapid diagnostic tests for COVID 19, Japan has ramped up the production of kits to scale-up testing. For instance, in March 2020, Osaka-based Kurabo Industries launched a 15- minute testing kit that was to be marketed in Japan.
In addition, Toyobo Co., a Japanese biotechnology company, developed a COVID-19 testing kit that can generate results within an hour. Similarly, in May 2020, Japanese authorities approved Fujirebio, Inc.'s SARS COV-2 antigen test kit. With this, the Japanese government planned to scale up the COVID-19 testing to up to 400,000 people per week.
Reasons to subscribe to Japan covid-19 diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan covid-19 diagnostics market databook
-
Our clientele includes a mix of covid-19 diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan covid-19 diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan covid-19 diagnostics market from 2020 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan covid-19 diagnostics market size, by product, 2020-2030 (US$M)
Japan COVID-19 Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
